25 of the Best Oncologists Near Me in Washington, DC
Oncologist Search Results
MediFind found 390 specialists near Washington, DC
Sibley Memorial Hospital
Edward Tanner, M.D., is a professor of gynecologic oncology in the Johns Hopkins Medicine Department of Gynecology and Obstetrics and the medical director for women’s health in the Johns Hopkins National Capital Region. Dr. Tanner is an internationally recognized expert in gynecologic surgery and is known for his surgical skills, compassionate bedside manner, leadership and teaching abilities. Dr. Tanner’s clinical interests include surgical management of advanced gynecologic cancers, including radical debulking surgery for ovarian cancer, as well as minimally invasive surgery for early-stage female cancers. He is particularly focused on developing innovative techniques that reduce complications and speed recovery time. His research interests include sentinel lymph node mapping in endometrial and cervical cancers, exploring ways to reduce complications for patients having surgery for advanced ovarian cancer, robotic single-site surgery and identifying new treatments for patients with uterine sarcoma. He has authored more than 80 articles in peer-reviewed medical journals and has lectured nationally and internationally on sentinel lymph node techniques, uterine sarcoma and surgical innovations for gynecologic cancer. He is the chapter author of “Surgery for Endometrial Cancer” in Telinde’s Operative Gynecology, the definitive textbook for gynecologic surgery techniques in the United States. Dr. Tanner is a member of the NRG Corpus Committee, which develops clinical trials for uterine cancer on behalf of the National Cancer Institute. A Maryland native, Dr. Tanner received his medical degree from the University of Alabama at Birmingham before returning to Baltimore to complete his residency in gynecology and obstetrics at The Johns Hopkins Hospital. He completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center, where he was among the first fellows to complete an extensive training program in robotic surgery for gynecologic cancers. Dr. Tanner has served as a faculty member at The Johns Hopkins Hospital as well as the Marcia Stenn Professor and chief of gynecologic oncology at Northwestern University in Chicago. Having served as the gynecologic oncology fellowship program director at both The Johns Hopkins Hospital and Northwestern Memorial Hospital, Dr. Tanner taught the next generation of gynecologic surgeons and health care leaders. Dr. Tanner-Iii is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy. Dr. Tanner-Iii is board certified in American Board Of Obstetrics And Gynecology. Dr. Tanner-Iii is currently accepting new patients.
Sibley Memorial Hospital
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner-Johnston is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wagner-Johnston is currently accepting new patients.
Sibley Memorial Hospital
Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa-Maria is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Santa-Maria is board certified in American Board Of Internal Medicine. Dr. Santa-Maria is currently accepting new patients.
MedStar Georgetown University Hospital
David Vesole is an Oncologist and a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Vesole is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine. Dr. Vesole is currently accepting new patients.
Sibley Memorial Hospital
Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Markowski is currently accepting new patients.
Sibley Memorial Hospital
Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El-Shami is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. El-Shami is currently accepting new patients.
Sibley Memorial Hospital
Dr. Gabrielle Prince is an Oncologist in Baltimore caring for patients with leukemias and other blood and bone marrow disorders. She is viewed regionally as a clinical expert in the care of patients with these disorders and has served as the Principal Investigator for numerous clinical trials studying new treatments for the most challenging clinical cases. Dr. Prince received her undergraduate degree in Biomedical Engineering from Columbia University (New York, NY), earned her M.D. at the State University of New York (Brooklyn, NY), completed her Residency at Columbia University Medical Center-New York Presbyterian (New York, NY), and Fellowship in Medical Oncology at Johns Hopkins (Baltimore, MD). Dr. Prince joined the Johns Hopkins faculty in 2014 at the completion of her training. Her main research interests include drug development for patients with AML, MDS, and MPDs. She has been involved in several clinical trials that helped lead to FDA approval of those new drugs and she remains interested in helping the program maintain a broad-based clinical trials portfolio. Dr. Prince is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Prince is currently accepting new patients.
Sibley Memorial Hospital
Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.
Office
Sandra Swain is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Swain is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and HER-2 Positive Breast Cancer.
Children's National Hospital
Emily Meier is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Meier is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Meier is currently accepting new patients.
Anchor Mental Health Association
James Goedert is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Goedert is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, Anal Cancer, and Colonoscopy.
Sibley Memorial Hospital
Larissa Korde is a Hematologist Oncology specialist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Korde is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Inflammatory Breast Cancer, and Menopause. Dr. Korde is board certified in American Board Of Internal Medicine. Dr. Korde is currently accepting new patients.
MedStar Georgetown Cancer Institute At MedStar Georgetown University Hospital
Benjamin Weinberg is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Weinberg is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Vertebroplasty. Dr. Weinberg is currently accepting new patients.
MedStar Georgetown University Hospital
Bruce Cheson is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Cheson is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Non-Hodgkin Lymphoma. Dr. Cheson is currently accepting new patients.
Sibley Memorial Hospital
Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine. Dr. Kressel is currently accepting new patients.
Children's National Hospital
Allistair Abraham is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Abraham is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.
MedStar Georgetown Cancer Institute At MedStar Georgetown University Hospital
Jeffrey Toretsky is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Toretsky is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Bone Tumor, and Bone Marrow Aspiration.
MedStar Georgetown Cancer Institute At MedStar Georgetown University Hospital
Gary Kupfer is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Kupfer is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Congenital Aplastic Anemia, Fanconi Anemia, Aplastic Anemia, and Anemia.
Children's National Hospital
Srivandana Akshintala is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Akshintala is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Multiple Endocrine Neoplasia, Medullary Thyroid Carcinoma, Neurofibromatosis, Neurofibromatosis Type 1 (NF1), and Thyroidectomy.
Sibley Memorial Hospital
Karen Smith is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Smith is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.
Children's National Hospital
Anne Angiolillo is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Angiolillo is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Agranulocytosis, and Burkitt Lymphoma.
Johns Hopkins University
Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology. Dr. Smith is currently accepting new patients.
Sibley Memorial Hospital
Valerie Lee, M.D., is a medical oncologist with the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an instructor of medical oncology at Johns Hopkins University School of Medicine. Dr. Lee has an expertise in management of gastrointestinal malignancies, including gastric, colon and pancreatobiliary cancers. Dr. Lee earned her medical degree from the Columbia University College of Physicians and Surgeons. She completed a residency in internal medicine at New York Presbyterian Hospital, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine. Dr. Lee is currently earning her Certificate in Science of Clinical Investigation at Johns Hopkins Bloomberg School of Public Health. Dr. Lee is a member of the American Society of Clinical Oncology. Dr. Lee manages multiple early phase trials and her work has been published in peer-reviewed journals. Her research interests include clinical trials for patients with gastrointestinal malignancies, and combining traditional chemotherapies with immunotherapy to improve survival and quality of life for patients. She has received a Cancer Center Training grant for research on molecular targets for cancer detection and treatment and has spoken at numerous conferences on updates in gastrointestinal malignancies. Dr. Lee is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Pancreaticoduodenectomy. Dr. Lee is board certified in American Board Of Internal Medicine. Dr. Lee is currently accepting new patients.
Nih Clinical Center
Wyndham Wilson is an Oncologist practicing medicine in Bethesda, Maryland. Dr. Wilson is highly rated in 12 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.
Johns Hopkins University
Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine. Dr. Paller is currently accepting new patients.
What is an oncologist?
An oncologist is a doctor who treats cancer. There are different types of oncologists who focus on specific kinds of treatments. Here are some examples:
- Medical oncologists use medications like chemotherapy, immunotherapy, and targeted therapies to fight cancer.
- Surgical oncologists perform operations to remove cancerous tumors or tissue.
- Radiation oncologists use high-energy radiation to destroy cancer cells.
- Pediatric oncologists focus on treating children and teens with cancer.
- Geriatric oncologists work with people with cancer who are 65 and older.
- Gynecologic oncologists treat cancers in reproductive organs for individuals assigned female at birth.
- Hematologist-oncologists treat cancers of the blood, such as leukemia, lymphoma, and multiple myeloma.
Why am I being referred to an oncologist?
You may be referred to an oncologist if your primary care doctor suspects you have cancer or another serious condition that requires specialized treatment. Oncologists are experts in diagnosing and treating cancer, but they also manage other conditions like blood disorders or abnormal cell growths that aren’t cancerous. For example, some people are referred to a hematologist-oncologist for issues with blood cells.
What tests are performed by an oncologist?
Oncologists use a variety of tests to help diagnose cancer and other serious conditions. These tests help them understand what stage the cancer is in or if the cancer has spread. Common tests include:
- Blood tests to check for abnormal cells, proteins, or other markers that might suggest cancer.
- Biopsies, where a small tissue sample is taken from a suspected area to check for cancer cells.
- Imaging tests like CT scans, MRIs, X-rays, and PET scans, which help oncologists get a detailed picture of what’s happening inside the body.
What treatments are available to me?
The type of treatment you receive depends on the kind of cancer, its stage, and your overall health. Treatment usually begins soon after diagnosis, depending on how quickly care needs to start. Your oncologist will guide you through the different treatment options and help you decide on the best approach.
Some common treatments include:
The type of treatment you receive depends on the kind of cancer, its stage, and your overall health. Treatment usually begins soon after diagnosis, depending on how quickly care needs to start. Your oncologist will guide you through the different treatment options and help you decide on the best approach.
Some common treatments include:
- Chemotherapy, which uses drugs to kill cancer cells.
- Radiation therapy, which uses high-energy rays to target and destroy cancer cells.
- Surgery, where tumors or cancerous tissue are physically removed from the body.
- Immunotherapy, which helps boost your immune system to fight cancer.
- Targeted therapy, which attacks specific changes in cancer cells that help them grow.
When should I see an Oncologist near Washington, DC?
There are various reasons why you may want to see a specialist, such as:
- Your primary care provider recommends it.
- Your condition requires expert knowledge and specialized care.
- Your symptoms persist or worsen despite treatment.
- You need specialized testing or procedures.
- You want a second opinion.
What should I consider when choosing a Oncologist near Washington, DC?
It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.
How do I find the best Oncologist near Washington, DC?
You can find an Oncologist in any of the 10 largest U.S. cities by clicking below:
Oncologist near New York, NY
Oncologist near Los Angeles, CA
Oncologist near Chicago, IL
Oncologist near Houston, TX
Oncologist near Phoenix, AZ
Oncologist near Philadelphia, PA
Oncologist near Atlanta, GA
Oncologist near Boston, MA
Oncologist near Dallas, TX
Oncologist near San Jose, CA
How does MediFind rank Oncologists near Washington, DC?
MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database.
What types of insurance are accepted by Oncologists near Washington, DC?
Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network.
How can I book an appointment online with a Oncologist in Washington?
MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Oncologist search results page.
Why is it important to get a second opinion from a different Oncologist?
Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.
How can I prepare for my appointment with a Oncologist near Washington, DC?
Prepare for your appointment by gathering the following items:
- Copies of medical records (dating back at least one year)
- Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see
- Family history of disease
- List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses
- Allergies to medications, food, latex, insects, etc.
- List of questions and concerns
- Your insurance card
You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit.
What questions should I ask my Oncologist?
Here are some sample questions:
- Can you explain in simple terms what this condition is and how it’s treated?
- What symptoms or side effects should I watch for?
- What tests will be involved, and when can I expect results?
- Are there other specialists I need to see?
- What’s the best way to reach you if I have follow-up questions?
How can I learn about the latest clinical trials and research advances my Oncologist may know about?
MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you.
MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand.
Can I filter my search to show male or female Oncologists near Washington, DC?
Look for the filter feature on the left side of the Oncologist search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers.
What are the most common health conditions that an Oncologist near Washington, DC might treat?
Can I filter my search to find a Oncologist that offers video calls?
Look for the filter feature on the left-side of the Oncologist search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls).










